COVID-19 Impact on Global IVD Infectious Diseases Market Size, Status and Forecast 2020-2026

August 2020 | 128 pages | ID: C3027AD53089EN
QYResearch

Abstracts

This report focuses on the global IVD Infectious Diseases status, future forecast, growth opportunity, key market and key players. The study objectives are to present the IVD Infectious Diseases development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• BD
• BioMerieux
• Abbott
• Quidel
• Gen-Probe
• Abbott
• Danaher
• Sysmex
• Orasure
• Hologic
• Cepheid
• Qiagen
• Roche Diagnostics
• Siemens Healthcare
• Bio-Rad Laboratories

Market segment by Type, the product can be split into

• Immunochemistry
• Molecular Diagnostics

Market segment by Application, split into

• Clinical Laboratories
• Diagnostic Centers

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global IVD Infectious Diseases status, future forecast, growth opportunity, key market and key players.
• To present the IVD Infectious Diseases development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of IVD Infectious Diseases are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by IVD Infectious Diseases Revenue
1.4 Market Analysis by Type
  1.4.1 Global IVD Infectious Diseases Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Immunochemistry
  1.4.3 Molecular Diagnostics
1.5 Market by Application
  1.5.1 Global IVD Infectious Diseases Market Share by Application: 2020 VS 2026
  1.5.2 Clinical Laboratories
  1.5.3 Diagnostic Centers
1.6 Coronavirus Disease 2019 (Covid-19): IVD Infectious Diseases Industry Impact
  1.6.1 How the Covid-19 is Affecting the IVD Infectious Diseases Industry
    1.6.1.1 IVD Infectious Diseases Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and IVD Infectious Diseases Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for IVD Infectious Diseases Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 IVD Infectious Diseases Market Perspective (2015-2026)
2.2 IVD Infectious Diseases Growth Trends by Regions
  2.2.1 IVD Infectious Diseases Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 IVD Infectious Diseases Historic Market Share by Regions (2015-2020)
  2.2.3 IVD Infectious Diseases Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 IVD Infectious Diseases Market Growth Strategy
  2.3.6 Primary Interviews with Key IVD Infectious Diseases Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top IVD Infectious Diseases Players by Market Size
  3.1.1 Global Top IVD Infectious Diseases Players by Revenue (2015-2020)
  3.1.2 Global IVD Infectious Diseases Revenue Market Share by Players (2015-2020)
  3.1.3 Global IVD Infectious Diseases Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global IVD Infectious Diseases Market Concentration Ratio
  3.2.1 Global IVD Infectious Diseases Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by IVD Infectious Diseases Revenue in 2019
3.3 IVD Infectious Diseases Key Players Head office and Area Served
3.4 Key Players IVD Infectious Diseases Product Solution and Service
3.5 Date of Enter into IVD Infectious Diseases Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global IVD Infectious Diseases Historic Market Size by Type (2015-2020)
4.2 Global IVD Infectious Diseases Forecasted Market Size by Type (2021-2026)

5 IVD INFECTIOUS DISEASES BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global IVD Infectious Diseases Market Size by Application (2015-2020)
5.2 Global IVD Infectious Diseases Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America IVD Infectious Diseases Market Size (2015-2020)
6.2 IVD Infectious Diseases Key Players in North America (2019-2020)
6.3 North America IVD Infectious Diseases Market Size by Type (2015-2020)
6.4 North America IVD Infectious Diseases Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe IVD Infectious Diseases Market Size (2015-2020)
7.2 IVD Infectious Diseases Key Players in Europe (2019-2020)
7.3 Europe IVD Infectious Diseases Market Size by Type (2015-2020)
7.4 Europe IVD Infectious Diseases Market Size by Application (2015-2020)

8 CHINA

8.1 China IVD Infectious Diseases Market Size (2015-2020)
8.2 IVD Infectious Diseases Key Players in China (2019-2020)
8.3 China IVD Infectious Diseases Market Size by Type (2015-2020)
8.4 China IVD Infectious Diseases Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan IVD Infectious Diseases Market Size (2015-2020)
9.2 IVD Infectious Diseases Key Players in Japan (2019-2020)
9.3 Japan IVD Infectious Diseases Market Size by Type (2015-2020)
9.4 Japan IVD Infectious Diseases Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia IVD Infectious Diseases Market Size (2015-2020)
10.2 IVD Infectious Diseases Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia IVD Infectious Diseases Market Size by Type (2015-2020)
10.4 Southeast Asia IVD Infectious Diseases Market Size by Application (2015-2020)

11 INDIA

11.1 India IVD Infectious Diseases Market Size (2015-2020)
11.2 IVD Infectious Diseases Key Players in India (2019-2020)
11.3 India IVD Infectious Diseases Market Size by Type (2015-2020)
11.4 India IVD Infectious Diseases Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America IVD Infectious Diseases Market Size (2015-2020)
12.2 IVD Infectious Diseases Key Players in Central & South America (2019-2020)
12.3 Central & South America IVD Infectious Diseases Market Size by Type (2015-2020)
12.4 Central & South America IVD Infectious Diseases Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 BD
  13.1.1 BD Company Details
  13.1.2 BD Business Overview and Its Total Revenue
  13.1.3 BD IVD Infectious Diseases Introduction
  13.1.4 BD Revenue in IVD Infectious Diseases Business (2015-2020))
  13.1.5 BD Recent Development
13.2 BioMerieux
  13.2.1 BioMerieux Company Details
  13.2.2 BioMerieux Business Overview and Its Total Revenue
  13.2.3 BioMerieux IVD Infectious Diseases Introduction
  13.2.4 BioMerieux Revenue in IVD Infectious Diseases Business (2015-2020)
  13.2.5 BioMerieux Recent Development
13.3 Abbott
  13.3.1 Abbott Company Details
  13.3.2 Abbott Business Overview and Its Total Revenue
  13.3.3 Abbott IVD Infectious Diseases Introduction
  13.3.4 Abbott Revenue in IVD Infectious Diseases Business (2015-2020)
  13.3.5 Abbott Recent Development
13.4 Quidel
  13.4.1 Quidel Company Details
  13.4.2 Quidel Business Overview and Its Total Revenue
  13.4.3 Quidel IVD Infectious Diseases Introduction
  13.4.4 Quidel Revenue in IVD Infectious Diseases Business (2015-2020)
  13.4.5 Quidel Recent Development
13.5 Gen-Probe
  13.5.1 Gen-Probe Company Details
  13.5.2 Gen-Probe Business Overview and Its Total Revenue
  13.5.3 Gen-Probe IVD Infectious Diseases Introduction
  13.5.4 Gen-Probe Revenue in IVD Infectious Diseases Business (2015-2020)
  13.5.5 Gen-Probe Recent Development
13.6 Abbott
  13.6.1 Abbott Company Details
  13.6.2 Abbott Business Overview and Its Total Revenue
  13.6.3 Abbott IVD Infectious Diseases Introduction
  13.6.4 Abbott Revenue in IVD Infectious Diseases Business (2015-2020)
  13.6.5 Abbott Recent Development
13.7 Danaher
  13.7.1 Danaher Company Details
  13.7.2 Danaher Business Overview and Its Total Revenue
  13.7.3 Danaher IVD Infectious Diseases Introduction
  13.7.4 Danaher Revenue in IVD Infectious Diseases Business (2015-2020)
  13.7.5 Danaher Recent Development
13.8 Sysmex
  13.8.1 Sysmex Company Details
  13.8.2 Sysmex Business Overview and Its Total Revenue
  13.8.3 Sysmex IVD Infectious Diseases Introduction
  13.8.4 Sysmex Revenue in IVD Infectious Diseases Business (2015-2020)
  13.8.5 Sysmex Recent Development
13.9 Orasure
  13.9.1 Orasure Company Details
  13.9.2 Orasure Business Overview and Its Total Revenue
  13.9.3 Orasure IVD Infectious Diseases Introduction
  13.9.4 Orasure Revenue in IVD Infectious Diseases Business (2015-2020)
  13.9.5 Orasure Recent Development
13.10 Hologic
  13.10.1 Hologic Company Details
  13.10.2 Hologic Business Overview and Its Total Revenue
  13.10.3 Hologic IVD Infectious Diseases Introduction
  13.10.4 Hologic Revenue in IVD Infectious Diseases Business (2015-2020)
  13.10.5 Hologic Recent Development
13.11 Cepheid
  10.11.1 Cepheid Company Details
  10.11.2 Cepheid Business Overview and Its Total Revenue
  10.11.3 Cepheid IVD Infectious Diseases Introduction
  10.11.4 Cepheid Revenue in IVD Infectious Diseases Business (2015-2020)
  10.11.5 Cepheid Recent Development
13.12 Qiagen
  10.12.1 Qiagen Company Details
  10.12.2 Qiagen Business Overview and Its Total Revenue
  10.12.3 Qiagen IVD Infectious Diseases Introduction
  10.12.4 Qiagen Revenue in IVD Infectious Diseases Business (2015-2020)
  10.12.5 Qiagen Recent Development
13.13 Roche Diagnostics
  10.13.1 Roche Diagnostics Company Details
  10.13.2 Roche Diagnostics Business Overview and Its Total Revenue
  10.13.3 Roche Diagnostics IVD Infectious Diseases Introduction
  10.13.4 Roche Diagnostics Revenue in IVD Infectious Diseases Business (2015-2020)
  10.13.5 Roche Diagnostics Recent Development
13.14 Siemens Healthcare
  10.14.1 Siemens Healthcare Company Details
  10.14.2 Siemens Healthcare Business Overview and Its Total Revenue
  10.14.3 Siemens Healthcare IVD Infectious Diseases Introduction
  10.14.4 Siemens Healthcare Revenue in IVD Infectious Diseases Business (2015-2020)
  10.14.5 Siemens Healthcare Recent Development
13.15 Bio-Rad Laboratories
  10.15.1 Bio-Rad Laboratories Company Details
  10.15.2 Bio-Rad Laboratories Business Overview and Its Total Revenue
  10.15.3 Bio-Rad Laboratories IVD Infectious Diseases Introduction
  10.15.4 Bio-Rad Laboratories Revenue in IVD Infectious Diseases Business (2015-2020)
  10.15.5 Bio-Rad Laboratories Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. IVD Infectious Diseases Key Market Segments
Table 2. Key Players Covered: Ranking by IVD Infectious Diseases Revenue
Table 3. Ranking of Global Top IVD Infectious Diseases Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global IVD Infectious Diseases Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Immunochemistry
Table 6. Key Players of Molecular Diagnostics
Table 7. COVID-19 Impact Global Market: (Four IVD Infectious Diseases Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for IVD Infectious Diseases Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for IVD Infectious Diseases Players to Combat Covid-19 Impact
Table 12. Global IVD Infectious Diseases Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global IVD Infectious Diseases Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global IVD Infectious Diseases Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global IVD Infectious Diseases Market Share by Regions (2015-2020)
Table 16. Global IVD Infectious Diseases Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global IVD Infectious Diseases Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. IVD Infectious Diseases Market Growth Strategy
Table 22. Main Points Interviewed from Key IVD Infectious Diseases Players
Table 23. Global IVD Infectious Diseases Revenue by Players (2015-2020) (Million US$)
Table 24. Global IVD Infectious Diseases Market Share by Players (2015-2020)
Table 25. Global Top IVD Infectious Diseases Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in IVD Infectious Diseases as of 2019)
Table 26. Global IVD Infectious Diseases by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players IVD Infectious Diseases Product Solution and Service
Table 29. Date of Enter into IVD Infectious Diseases Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global IVD Infectious Diseases Market Size by Type (2015-2020) (Million US$)
Table 32. Global IVD Infectious Diseases Market Size Share by Type (2015-2020)
Table 33. Global IVD Infectious Diseases Revenue Market Share by Type (2021-2026)
Table 34. Global IVD Infectious Diseases Market Size Share by Application (2015-2020)
Table 35. Global IVD Infectious Diseases Market Size by Application (2015-2020) (Million US$)
Table 36. Global IVD Infectious Diseases Market Size Share by Application (2021-2026)
Table 37. North America Key Players IVD Infectious Diseases Revenue (2019-2020) (Million US$)
Table 38. North America Key Players IVD Infectious Diseases Market Share (2019-2020)
Table 39. North America IVD Infectious Diseases Market Size by Type (2015-2020) (Million US$)
Table 40. North America IVD Infectious Diseases Market Share by Type (2015-2020)
Table 41. North America IVD Infectious Diseases Market Size by Application (2015-2020) (Million US$)
Table 42. North America IVD Infectious Diseases Market Share by Application (2015-2020)
Table 43. Europe Key Players IVD Infectious Diseases Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players IVD Infectious Diseases Market Share (2019-2020)
Table 45. Europe IVD Infectious Diseases Market Size by Type (2015-2020) (Million US$)
Table 46. Europe IVD Infectious Diseases Market Share by Type (2015-2020)
Table 47. Europe IVD Infectious Diseases Market Size by Application (2015-2020) (Million US$)
Table 48. Europe IVD Infectious Diseases Market Share by Application (2015-2020)
Table 49. China Key Players IVD Infectious Diseases Revenue (2019-2020) (Million US$)
Table 50. China Key Players IVD Infectious Diseases Market Share (2019-2020)
Table 51. China IVD Infectious Diseases Market Size by Type (2015-2020) (Million US$)
Table 52. China IVD Infectious Diseases Market Share by Type (2015-2020)
Table 53. China IVD Infectious Diseases Market Size by Application (2015-2020) (Million US$)
Table 54. China IVD Infectious Diseases Market Share by Application (2015-2020)
Table 55. Japan Key Players IVD Infectious Diseases Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players IVD Infectious Diseases Market Share (2019-2020)
Table 57. Japan IVD Infectious Diseases Market Size by Type (2015-2020) (Million US$)
Table 58. Japan IVD Infectious Diseases Market Share by Type (2015-2020)
Table 59. Japan IVD Infectious Diseases Market Size by Application (2015-2020) (Million US$)
Table 60. Japan IVD Infectious Diseases Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players IVD Infectious Diseases Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players IVD Infectious Diseases Market Share (2019-2020)
Table 63. Southeast Asia IVD Infectious Diseases Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia IVD Infectious Diseases Market Share by Type (2015-2020)
Table 65. Southeast Asia IVD Infectious Diseases Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia IVD Infectious Diseases Market Share by Application (2015-2020)
Table 67. India Key Players IVD Infectious Diseases Revenue (2019-2020) (Million US$)
Table 68. India Key Players IVD Infectious Diseases Market Share (2019-2020)
Table 69. India IVD Infectious Diseases Market Size by Type (2015-2020) (Million US$)
Table 70. India IVD Infectious Diseases Market Share by Type (2015-2020)
Table 71. India IVD Infectious Diseases Market Size by Application (2015-2020) (Million US$)
Table 72. India IVD Infectious Diseases Market Share by Application (2015-2020)
Table 73. Central & South America Key Players IVD Infectious Diseases Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players IVD Infectious Diseases Market Share (2019-2020)
Table 75. Central & South America IVD Infectious Diseases Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America IVD Infectious Diseases Market Share by Type (2015-2020)
Table 77. Central & South America IVD Infectious Diseases Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America IVD Infectious Diseases Market Share by Application (2015-2020)
Table 79. BD Company Details
Table 80. BD Business Overview
Table 81. BD Product
Table 82. BD Revenue in IVD Infectious Diseases Business (2015-2020) (Million US$)
Table 83. BD Recent Development
Table 84. BioMerieux Company Details
Table 85. BioMerieux Business Overview
Table 86. BioMerieux Product
Table 87. BioMerieux Revenue in IVD Infectious Diseases Business (2015-2020) (Million US$)
Table 88. BioMerieux Recent Development
Table 89. Abbott Company Details
Table 90. Abbott Business Overview
Table 91. Abbott Product
Table 92. Abbott Revenue in IVD Infectious Diseases Business (2015-2020) (Million US$)
Table 93. Abbott Recent Development
Table 94. Quidel Company Details
Table 95. Quidel Business Overview
Table 96. Quidel Product
Table 97. Quidel Revenue in IVD Infectious Diseases Business (2015-2020) (Million US$)
Table 98. Quidel Recent Development
Table 99. Gen-Probe Company Details
Table 100. Gen-Probe Business Overview
Table 101. Gen-Probe Product
Table 102. Gen-Probe Revenue in IVD Infectious Diseases Business (2015-2020) (Million US$)
Table 103. Gen-Probe Recent Development
Table 104. Abbott Company Details
Table 105. Abbott Business Overview
Table 106. Abbott Product
Table 107. Abbott Revenue in IVD Infectious Diseases Business (2015-2020) (Million US$)
Table 108. Abbott Recent Development
Table 109. Danaher Company Details
Table 110. Danaher Business Overview
Table 111. Danaher Product
Table 112. Danaher Revenue in IVD Infectious Diseases Business (2015-2020) (Million US$)
Table 113. Danaher Recent Development
Table 114. Sysmex Business Overview
Table 115. Sysmex Product
Table 116. Sysmex Company Details
Table 117. Sysmex Revenue in IVD Infectious Diseases Business (2015-2020) (Million US$)
Table 118. Sysmex Recent Development
Table 119. Orasure Company Details
Table 120. Orasure Business Overview
Table 121. Orasure Product
Table 122. Orasure Revenue in IVD Infectious Diseases Business (2015-2020) (Million US$)
Table 123. Orasure Recent Development
Table 124. Hologic Company Details
Table 125. Hologic Business Overview
Table 126. Hologic Product
Table 127. Hologic Revenue in IVD Infectious Diseases Business (2015-2020) (Million US$)
Table 128. Hologic Recent Development
Table 129. Cepheid Company Details
Table 130. Cepheid Business Overview
Table 131. Cepheid Product
Table 132. Cepheid Revenue in IVD Infectious Diseases Business (2015-2020) (Million US$)
Table 133. Cepheid Recent Development
Table 134. Qiagen Company Details
Table 135. Qiagen Business Overview
Table 136. Qiagen Product
Table 137. Qiagen Revenue in IVD Infectious Diseases Business (2015-2020) (Million US$)
Table 138. Qiagen Recent Development
Table 139. Roche Diagnostics Company Details
Table 140. Roche Diagnostics Business Overview
Table 141. Roche Diagnostics Product
Table 142. Roche Diagnostics Revenue in IVD Infectious Diseases Business (2015-2020) (Million US$)
Table 143. Roche Diagnostics Recent Development
Table 144. Siemens Healthcare Company Details
Table 145. Siemens Healthcare Business Overview
Table 146. Siemens Healthcare Product
Table 147. Siemens Healthcare Revenue in IVD Infectious Diseases Business (2015-2020) (Million US$)
Table 148. Siemens Healthcare Recent Development
Table 149. Bio-Rad Laboratories Company Details
Table 150. Bio-Rad Laboratories Business Overview
Table 151. Bio-Rad Laboratories Product
Table 152. Bio-Rad Laboratories Revenue in IVD Infectious Diseases Business (2015-2020) (Million US$)
Table 153. Bio-Rad Laboratories Recent Development
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global IVD Infectious Diseases Market Share by Type: 2020 VS 2026
Figure 2. Immunochemistry Features
Figure 3. Molecular Diagnostics Features
Figure 4. Global IVD Infectious Diseases Market Share by Application: 2020 VS 2026
Figure 5. Clinical Laboratories Case Studies
Figure 6. Diagnostic Centers Case Studies
Figure 7. IVD Infectious Diseases Report Years Considered
Figure 8. Global IVD Infectious Diseases Market Size YoY Growth 2015-2026 (US$ Million)
Figure 9. Global IVD Infectious Diseases Market Share by Regions: 2020 VS 2026
Figure 10. Global IVD Infectious Diseases Market Share by Regions (2021-2026)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global IVD Infectious Diseases Market Share by Players in 2019
Figure 13. Global Top IVD Infectious Diseases Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in IVD Infectious Diseases as of 2019
Figure 14. The Top 10 and 5 Players Market Share by IVD Infectious Diseases Revenue in 2019
Figure 15. North America IVD Infectious Diseases Market Size YoY Growth (2015-2020) (Million US$)
Figure 16. Europe IVD Infectious Diseases Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. China IVD Infectious Diseases Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Japan IVD Infectious Diseases Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Southeast Asia IVD Infectious Diseases Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. India IVD Infectious Diseases Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Central & South America IVD Infectious Diseases Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. BD Total Revenue (US$ Million): 2019 Compared with 2018
Figure 23. BD Revenue Growth Rate in IVD Infectious Diseases Business (2015-2020)
Figure 24. BioMerieux Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. BioMerieux Revenue Growth Rate in IVD Infectious Diseases Business (2015-2020)
Figure 26. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Abbott Revenue Growth Rate in IVD Infectious Diseases Business (2015-2020)
Figure 28. Quidel Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Quidel Revenue Growth Rate in IVD Infectious Diseases Business (2015-2020)
Figure 30. Gen-Probe Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Gen-Probe Revenue Growth Rate in IVD Infectious Diseases Business (2015-2020)
Figure 32. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Abbott Revenue Growth Rate in IVD Infectious Diseases Business (2015-2020)
Figure 34. Danaher Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Danaher Revenue Growth Rate in IVD Infectious Diseases Business (2015-2020)
Figure 36. Sysmex Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Sysmex Revenue Growth Rate in IVD Infectious Diseases Business (2015-2020)
Figure 38. Orasure Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Orasure Revenue Growth Rate in IVD Infectious Diseases Business (2015-2020)
Figure 40. Hologic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Hologic Revenue Growth Rate in IVD Infectious Diseases Business (2015-2020)
Figure 42. Cepheid Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Cepheid Revenue Growth Rate in IVD Infectious Diseases Business (2015-2020)
Figure 44. Qiagen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Qiagen Revenue Growth Rate in IVD Infectious Diseases Business (2015-2020)
Figure 46. Roche Diagnostics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Roche Diagnostics Revenue Growth Rate in IVD Infectious Diseases Business (2015-2020)
Figure 48. Siemens Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Siemens Healthcare Revenue Growth Rate in IVD Infectious Diseases Business (2015-2020)
Figure 50. Bio-Rad Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Bio-Rad Laboratories Revenue Growth Rate in IVD Infectious Diseases Business (2015-2020)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed